Millennium Laboratories, Inc., a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain, announced today a national agreement with MultiPlan, the nation's leading comprehensive provider of healthcare cost management solutions. As a participating provider in the PHCS and MultiPlan Networks, Millennium Laboratories will assist participating physicians with state-of-the-art therapeutic drug monitoring services and tools. MultiPlan contracts with over 700,000 total providers, including hospitals, ancillary care facilities and healthcare practitioners across the United States.
Under the agreement, Millennium will provide its industry-leading, fast turn-around time on drug test reporting and final confirmation of laboratory analysis results exclusively utilizing the latest cutting-edge technology, Liquid Chromatography/Mass Spectrometry/Mass Spectrometry (LC-MS/MS). In addition, MultiPlan's participating providers will have access to Millennium's Hotline that provides phone consultations with the company's expert toxicologists about test results, drug interactions, and/or any other clinical topic of concern.
Dr. Paul Goldstein, MultiPlan Vice President & Corporate Medical Director said, "MultiPlan is committed to performance outcomes that enhance the care providers deliver to patients. Our agreement with Millennium creates the ability to provide enhanced quality pain management services."
James Slattery, Millennium Laboratories CEO, added, "We are pleased to participate in the PHCS and MultiPlan Networks to provide these vital services. Millennium has established a reputation for the highest standard of support in therapeutic drug monitoring and physician and staff education as well as original research in the field."
Millennium Laboratories, Inc.